Study guide
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods
ASCP MLT Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 ASCP MLT Exam Overview and Laboratory Operations
Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification
2 Chemistry, Urinalysis, and Body Fluid Interpretation
Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns
3 Hematology and Hemostasis
CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions
4 Blood Banking and Transfusion Practice
ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow
5 Microbiology Workups and Susceptibility Reasoning
Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting
6 Immunology, Integrated Cases, and Final Review
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods
Key Takeaways Explain This Topic AI
Immunology is an official ASCP MLT domain worth 5-10% of the 100-question CAT examination, so it deserves focused review without crowding out higher-weight domains.
Antigen-antibody binding explains most MLT immunology methods: agglutination, precipitation, labeled immunoassays, immunofluorescence, lateral flow, and reflex molecular testing.
Autoimmune markers are interpretation tools, not stand-alone diagnoses; titer, pattern, specificity, specimen quality, and clinical context all matter.
Infectious serology questions often test algorithm logic, such as screen-confirm-resolve steps for HIV, hepatitis B patterns, and syphilis treponemal/nontreponemal testing.
Molecular methods usually answer a different question than serology: nucleic acid tests detect pathogen genetic material, while serology detects host antibody or pathogen antigen.
Last updated: May 2026
Why This Section Matters
The ASCP MLT content guideline places Immunology at 5-10% of the examination. That is a smaller domain than chemistry, hematology, blood banking, or microbiology, but it is not a throwaway. Immunology also shows up inside other departments: blood bank antigen-antibody reactions, chemistry immunoassays, microbiology rapid antigen tests, and lab operations questions about quality control or reflex algorithms.
Study immunology as a reasoning system. The exam is less likely to reward memorizing a long list of antibodies in isolation and more likely to ask what a result means, what confirmation is needed, or why a method fits the clinical question.
Core Immune Concepts For MLT Questions
Innate immunity is the immediate, nonspecific defense system. It includes physical barriers, phagocytes, natural killer cells, cytokines, inflammation, and complement. Adaptive immunity is antigen specific and includes B cells, T cells, antibodies, and memory responses.
A first exposure usually produces a slower primary response with early IgM and later class switching. A repeated exposure produces a faster secondary response , usually dominated by higher-affinity IgG. That distinction supports vaccine serology, hepatitis B marker interpretation, transfusion antibody history, and transplant compatibility reasoning.
- Concept MLT-Level Exam Use
- Antigen Target recognized by antibody, T-cell receptor, or assay reagent
- Antibody Immunoglobulin that binds antigen through specific variable regions
- Affinity Strength of one binding site for one epitope
- Avidity Overall binding strength when multiple sites interact
- Sensitivity Ability to detect disease or target when it is present
- Specificity Ability to exclude disease or target when it is absent
- Titer Highest dilution that still gives a defined reactive result
- Antigen-Antibody Methods
Most bench methods in this domain are built from the same idea: a specific binding event becomes visible through clumping, color, fluorescence, chemiluminescence, turbidity, or a molecular signal.
- Method What The Signal Usually Means Common MLT Use
- Agglutination Particles cross-link into visible clumps Latex RF, some infectious screens, blood bank reactions
Enzyme-linked immunosorbent assay (ELISA) Enzyme label generates color Viral serology, autoimmune markers, hormones in chemistry
- Chemiluminescent immunoassay Label emits light after reaction High-throughput infectious and endocrine testing
- Indirect immunofluorescence Antibody binding is seen by fluorescent microscopy ANA pattern and titer screening
Immunoblot or line assay Antibodies bind separated or fixed antigen bands Supplemental or characterization testing in selected algorithms
Nucleic acid test (NAT/NAAT) Pathogen DNA or RNA is amplified or detected Resolving early infection or discordant serology
Know what each method detects. A fourth-generation HIV screen detects HIV antigen and antibody; a supplemental differentiation immunoassay helps distinguish HIV-1 from HIV-2 antibody; a nucleic acid test helps resolve possible acute infection when serology is discordant. Hepatitis serology detects combinations of antigen and antibody, while viral load testing detects nucleic acid.
Autoimmune Serology: Pattern First, Then Specificity
Autoimmune testing is a classic source of overcalling. A positive screen is not a diagnosis by itself. Interpretation depends on the patient picture, the strength of reactivity, the pattern, and the follow-up antibody.
Marker High-Yield Association Interpretation Caution
ANA Systemic autoimmune disease screening, especially systemic lupus erythematosus Sensitive but nonspecific; low titers can occur without systemic disease
Anti-dsDNA Systemic lupus erythematosus, often disease activity or nephritis risk correlation Interpret with ANA, complement, urinalysis, and clinical findings
Anti-Sm Systemic lupus erythematosus More specific but less sensitive than ANA
Rheumatoid factor Rheumatoid arthritis and other inflammatory states Less specific; can be positive in infection or older adults
- Anti-CCP Rheumatoid arthritis More specific than rheumatoid factor and useful when symptoms fit
- Anti-mitochondrial antibody Primary biliary cholangitis Correlate with cholestatic liver enzymes
- Anti-GBM Anti-glomerular basement membrane disease Urgent correlation with renal and pulmonary findings
For MLT-level review, think in paired evidence. ANA plus anti-dsDNA plus low complement plus proteinuria is a stronger lupus-nephritis pattern than ANA alone. Anti-CCP plus inflammatory small-joint symptoms is stronger rheumatoid arthritis evidence than rheumatoid factor alone. AMA plus alkaline phosphatase elevation supports a cholestatic autoimmune pattern more than AMA in isolation.
Infectious Serology Algorithms
Infectious serology often tests sequence and interpretation. A screen is designed to catch likely positives; a supplemental or confirmatory step improves specificity or resolves discordance.
HIV
A common laboratory algorithm starts with an HIV-1/HIV-2 antigen/antibody combination immunoassay. If it is repeatedly reactive, a supplemental HIV-1/HIV-2 differentiation immunoassay follows. If the screen is reactive but the differentiation assay is negative or indeterminate, a nucleic acid test is used to evaluate possible acute infection.
Hepatitis B
HBsAg suggests current infection. Anti-HBs suggests immunity. Total anti-HBc means exposure to core antigen through infection, not vaccination alone. IgM anti-HBc points toward recent or acute infection.
- HBsAg Total/IgM anti-HBc Anti-HBs Usual Interpretation
- Positive IgM positive Negative Acute hepatitis B pattern
- Negative Negative Positive Immunity from vaccination pattern
- Negative Total anti-HBc positive Positive Resolved natural infection pattern
- Positive Total anti-HBc positive, IgM negative Negative Chronic infection pattern, if persistent
- Negative Total anti-HBc positive Negative Isolated core antibody; needs clinical/reflex correlation
- Syphilis
Nontreponemal tests such as RPR or VDRL are useful for screening activity and following titers, but they can have biologic false positives. Treponemal tests are more specific for exposure to Treponema pallidum and often remain reactive after treatment. Traditional and reverse algorithms both require reconciling treponemal and nontreponemal results rather than treating one reactive result as the whole answer.
How To Answer Immunology Method Questions
Use this four-step approach:
Identify the target: antigen, antibody, immune complex, complement, or nucleic acid.
Identify the method: agglutination, immunoassay, immunofluorescence, electrophoresis, or molecular test.
Decide whether the result is screening, supplemental, confirmatory, or monitoring.
Correlate with timing, disease state, specimen quality, and reflex requirements.
A good MLT answer usually respects the algorithm. Do not skip from a reactive screen straight to final diagnosis if the prompt gives a known confirmatory pathway.